nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—SLC22A6—Furosemide—dilated cardiomyopathy	0.231	0.418	CbGbCtD
Levofloxacin—ABCB1—Lisinopril—dilated cardiomyopathy	0.171	0.31	CbGbCtD
Levofloxacin—ABCB1—Spironolactone—dilated cardiomyopathy	0.151	0.273	CbGbCtD
Levofloxacin—SLC22A4—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0143	0.215	CbGpPWpGaD
Levofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0097	0.146	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00677	0.102	CbGpPWpGaD
Levofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0055	0.0827	CbGpPWpGaD
Levofloxacin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00459	0.069	CbGpPWpGaD
Levofloxacin—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.00408	1	CbGdCrCtD
Levofloxacin—Sparfloxacin—SLC22A5—dilated cardiomyopathy	0.00395	0.323	CrCbGaD
Levofloxacin—Lomefloxacin—SLC22A5—dilated cardiomyopathy	0.00325	0.266	CrCbGaD
Levofloxacin—Ofloxacin—SLC22A5—dilated cardiomyopathy	0.00278	0.227	CrCbGaD
Levofloxacin—Norfloxacin—SLC22A5—dilated cardiomyopathy	0.00225	0.184	CrCbGaD
Levofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00194	0.0292	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00162	0.0244	CbGpPWpGaD
Levofloxacin—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00145	0.00399	CcSEcCtD
Levofloxacin—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00143	0.00394	CcSEcCtD
Levofloxacin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0014	0.00386	CcSEcCtD
Levofloxacin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0014	0.00384	CcSEcCtD
Levofloxacin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.0014	0.00384	CcSEcCtD
Levofloxacin—Thirst—Furosemide—dilated cardiomyopathy	0.00139	0.00381	CcSEcCtD
Levofloxacin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00138	0.00379	CcSEcCtD
Levofloxacin—Purpura—Furosemide—dilated cardiomyopathy	0.00137	0.00376	CcSEcCtD
Levofloxacin—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00136	0.00375	CcSEcCtD
Levofloxacin—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00136	0.00375	CcSEcCtD
Levofloxacin—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00136	0.00375	CcSEcCtD
Levofloxacin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00136	0.00372	CcSEcCtD
Levofloxacin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00134	0.00368	CcSEcCtD
Levofloxacin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00132	0.00364	CcSEcCtD
Levofloxacin—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00132	0.00364	CcSEcCtD
Levofloxacin—Malaise—Spironolactone—dilated cardiomyopathy	0.00132	0.00362	CcSEcCtD
Levofloxacin—Cystitis—Lisinopril—dilated cardiomyopathy	0.00132	0.00362	CcSEcCtD
Levofloxacin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00131	0.00359	CcSEcCtD
Levofloxacin—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00129	0.00354	CcSEcCtD
Levofloxacin—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00128	0.00352	CcSEcCtD
Levofloxacin—Photophobia—Lisinopril—dilated cardiomyopathy	0.00128	0.00352	CcSEcCtD
Levofloxacin—Urinary retention—Furosemide—dilated cardiomyopathy	0.00125	0.00345	CcSEcCtD
Levofloxacin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00124	0.0034	CcSEcCtD
Levofloxacin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00123	0.00338	CcSEcCtD
Levofloxacin—Dehydration—Furosemide—dilated cardiomyopathy	0.00123	0.00337	CcSEcCtD
Levofloxacin—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00122	0.00335	CcSEcCtD
Levofloxacin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00121	0.00334	CcSEcCtD
Levofloxacin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00121	0.00331	CcSEcCtD
Levofloxacin—Confusional state—Spironolactone—dilated cardiomyopathy	0.0012	0.0033	CcSEcCtD
Levofloxacin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0012	0.0033	CcSEcCtD
Levofloxacin—Hypertonia—Lisinopril—dilated cardiomyopathy	0.0012	0.00329	CcSEcCtD
Levofloxacin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00119	0.00328	CcSEcCtD
Levofloxacin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00119	0.00327	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00119	0.00327	CcSEcCtD
Levofloxacin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00117	0.00321	CcSEcCtD
Levofloxacin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00115	0.00316	CcSEcCtD
Levofloxacin—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00314	CcSEcCtD
Levofloxacin—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00114	0.00313	CcSEcCtD
Levofloxacin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00113	0.00311	CcSEcCtD
Levofloxacin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00113	0.0031	CcSEcCtD
Levofloxacin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00113	0.0031	CcSEcCtD
Levofloxacin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00112	0.00307	CcSEcCtD
Levofloxacin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00112	0.00307	CcSEcCtD
Levofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.0011	0.0166	CbGpPWpGaD
Levofloxacin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.0011	0.00303	CcSEcCtD
Levofloxacin—Eczema—Lisinopril—dilated cardiomyopathy	0.0011	0.00303	CcSEcCtD
Levofloxacin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0011	0.00301	CcSEcCtD
Levofloxacin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00107	0.00295	CcSEcCtD
Levofloxacin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00106	0.00291	CcSEcCtD
Levofloxacin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00105	0.0029	CcSEcCtD
Levofloxacin—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00104	0.00287	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00104	0.00286	CcSEcCtD
Levofloxacin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00104	0.00286	CcSEcCtD
Levofloxacin—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00103	0.0155	CbGpPWpGaD
Levofloxacin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00103	0.00283	CcSEcCtD
Levofloxacin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00103	0.00283	CcSEcCtD
Levofloxacin—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00102	0.00281	CcSEcCtD
Levofloxacin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00102	0.0028	CcSEcCtD
Levofloxacin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00102	0.00279	CcSEcCtD
Levofloxacin—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00101	0.00279	CcSEcCtD
Levofloxacin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00101	0.00278	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00101	0.00277	CcSEcCtD
Levofloxacin—Renal failure—Furosemide—dilated cardiomyopathy	0.001	0.00275	CcSEcCtD
Levofloxacin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000994	0.00273	CcSEcCtD
Levofloxacin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00099	0.00272	CcSEcCtD
Levofloxacin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00099	0.00272	CcSEcCtD
Levofloxacin—Diplopia—Lisinopril—dilated cardiomyopathy	0.00099	0.00272	CcSEcCtD
Levofloxacin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000982	0.0027	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000962	0.00264	CcSEcCtD
Levofloxacin—Face oedema—Lisinopril—dilated cardiomyopathy	0.000956	0.00263	CcSEcCtD
Levofloxacin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000949	0.00261	CcSEcCtD
Levofloxacin—Urticaria—Spironolactone—dilated cardiomyopathy	0.000947	0.0026	CcSEcCtD
Levofloxacin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000942	0.00259	CcSEcCtD
Levofloxacin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000942	0.00259	CcSEcCtD
Levofloxacin—Ataxia—Lisinopril—dilated cardiomyopathy	0.000931	0.00256	CcSEcCtD
Levofloxacin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000928	0.00255	CcSEcCtD
Levofloxacin—Dehydration—Lisinopril—dilated cardiomyopathy	0.000921	0.00253	CcSEcCtD
Levofloxacin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000919	0.0138	CbGpPWpGaD
Levofloxacin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000904	0.00249	CcSEcCtD
Levofloxacin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000902	0.00248	CcSEcCtD
Levofloxacin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000895	0.00246	CcSEcCtD
Levofloxacin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000895	0.00246	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000892	0.00245	CcSEcCtD
Levofloxacin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000892	0.00245	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000887	0.0133	CbGpPWpGaD
Levofloxacin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000885	0.00243	CcSEcCtD
Levofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000883	0.0133	CbGpPWpGaD
Levofloxacin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00088	0.00242	CcSEcCtD
Levofloxacin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000878	0.00241	CcSEcCtD
Levofloxacin—Gastritis—Lisinopril—dilated cardiomyopathy	0.000876	0.00241	CcSEcCtD
Levofloxacin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000863	0.00237	CcSEcCtD
Levofloxacin—Asthma—Lisinopril—dilated cardiomyopathy	0.000856	0.00235	CcSEcCtD
Levofloxacin—Eye disorder—Furosemide—dilated cardiomyopathy	0.000853	0.00234	CcSEcCtD
Levofloxacin—Tinnitus—Furosemide—dilated cardiomyopathy	0.000851	0.00234	CcSEcCtD
Levofloxacin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000847	0.00233	CcSEcCtD
Levofloxacin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000843	0.00232	CcSEcCtD
Levofloxacin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000842	0.00231	CcSEcCtD
Levofloxacin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000839	0.00231	CcSEcCtD
Levofloxacin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000834	0.00229	CcSEcCtD
Levofloxacin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000834	0.00229	CcSEcCtD
Levofloxacin—Angiopathy—Furosemide—dilated cardiomyopathy	0.000828	0.00228	CcSEcCtD
Levofloxacin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000825	0.00227	CcSEcCtD
Levofloxacin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000823	0.00226	CcSEcCtD
Levofloxacin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000816	0.00224	CcSEcCtD
Levofloxacin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000816	0.00224	CcSEcCtD
Levofloxacin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000813	0.00223	CcSEcCtD
Levofloxacin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.0008	0.0022	CcSEcCtD
Levofloxacin—Dysuria—Lisinopril—dilated cardiomyopathy	0.0008	0.0022	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000795	0.00219	CcSEcCtD
Levofloxacin—Erythema—Furosemide—dilated cardiomyopathy	0.000795	0.00218	CcSEcCtD
Levofloxacin—Malnutrition—Furosemide—dilated cardiomyopathy	0.000795	0.00218	CcSEcCtD
Levofloxacin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000788	0.00217	CcSEcCtD
Levofloxacin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000788	0.00217	CcSEcCtD
Levofloxacin—Flatulence—Furosemide—dilated cardiomyopathy	0.000783	0.00215	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000781	0.00215	CcSEcCtD
Levofloxacin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000778	0.00214	CcSEcCtD
Levofloxacin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000774	0.00213	CcSEcCtD
Levofloxacin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000772	0.00212	CcSEcCtD
Levofloxacin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000767	0.00211	CcSEcCtD
Levofloxacin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000764	0.0021	CcSEcCtD
Levofloxacin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000758	0.00208	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000756	0.00208	CcSEcCtD
Levofloxacin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000752	0.00207	CcSEcCtD
Levofloxacin—Rash—Spironolactone—dilated cardiomyopathy	0.000752	0.00207	CcSEcCtD
Levofloxacin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000751	0.00206	CcSEcCtD
Levofloxacin—Renal failure—Lisinopril—dilated cardiomyopathy	0.00075	0.00206	CcSEcCtD
Levofloxacin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000749	0.00206	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000748	0.00206	CcSEcCtD
Levofloxacin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000748	0.00206	CcSEcCtD
Levofloxacin—Headache—Spironolactone—dilated cardiomyopathy	0.000747	0.00205	CcSEcCtD
Levofloxacin—Jaundice—Lisinopril—dilated cardiomyopathy	0.000744	0.00204	CcSEcCtD
Levofloxacin—Anaemia—Furosemide—dilated cardiomyopathy	0.000735	0.00202	CcSEcCtD
Levofloxacin—Agitation—Furosemide—dilated cardiomyopathy	0.00073	0.00201	CcSEcCtD
Levofloxacin—Haematuria—Lisinopril—dilated cardiomyopathy	0.000728	0.002	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000722	0.00198	CcSEcCtD
Levofloxacin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00072	0.00198	CcSEcCtD
Levofloxacin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000716	0.00197	CcSEcCtD
Levofloxacin—Vertigo—Furosemide—dilated cardiomyopathy	0.000714	0.00196	CcSEcCtD
Levofloxacin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000712	0.00196	CcSEcCtD
Levofloxacin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000711	0.00195	CcSEcCtD
Levofloxacin—Nausea—Spironolactone—dilated cardiomyopathy	0.000708	0.00195	CcSEcCtD
Levofloxacin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000697	0.00192	CcSEcCtD
Levofloxacin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000687	0.00189	CcSEcCtD
Levofloxacin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000685	0.00188	CcSEcCtD
Levofloxacin—Hallucination—Lisinopril—dilated cardiomyopathy	0.000682	0.00187	CcSEcCtD
Levofloxacin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00068	0.00187	CcSEcCtD
Levofloxacin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000676	0.00186	CcSEcCtD
Levofloxacin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000675	0.00185	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000672	0.00185	CcSEcCtD
Levofloxacin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000671	0.00185	CcSEcCtD
Levofloxacin—Dry mouth—Furosemide—dilated cardiomyopathy	0.000662	0.00182	CcSEcCtD
Levofloxacin—Confusional state—Furosemide—dilated cardiomyopathy	0.000654	0.0018	CcSEcCtD
Levofloxacin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000649	0.00178	CcSEcCtD
Levofloxacin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000648	0.00178	CcSEcCtD
Levofloxacin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000639	0.00176	CcSEcCtD
Levofloxacin—Shock—Furosemide—dilated cardiomyopathy	0.000638	0.00175	CcSEcCtD
Levofloxacin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000636	0.00175	CcSEcCtD
Levofloxacin—Flushing—Lisinopril—dilated cardiomyopathy	0.000636	0.00175	CcSEcCtD
Levofloxacin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000635	0.00175	CcSEcCtD
Levofloxacin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00063	0.00173	CcSEcCtD
Levofloxacin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000627	0.00172	CcSEcCtD
Levofloxacin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000621	0.00171	CcSEcCtD
Levofloxacin—Anorexia—Furosemide—dilated cardiomyopathy	0.000618	0.0017	CcSEcCtD
Levofloxacin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000617	0.0017	CcSEcCtD
Levofloxacin—Chills—Lisinopril—dilated cardiomyopathy	0.000615	0.00169	CcSEcCtD
Levofloxacin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000612	0.00168	CcSEcCtD
Levofloxacin—Hypotension—Furosemide—dilated cardiomyopathy	0.000606	0.00167	CcSEcCtD
Levofloxacin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000605	0.00166	CcSEcCtD
Levofloxacin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0006	0.00165	CcSEcCtD
Levofloxacin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000596	0.00164	CcSEcCtD
Levofloxacin—Erythema—Lisinopril—dilated cardiomyopathy	0.000596	0.00164	CcSEcCtD
Levofloxacin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000588	0.00161	CcSEcCtD
Levofloxacin—Tension—Lisinopril—dilated cardiomyopathy	0.000585	0.00161	CcSEcCtD
Levofloxacin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000584	0.0016	CcSEcCtD
Levofloxacin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000582	0.0016	CcSEcCtD
Levofloxacin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000579	0.00159	CcSEcCtD
Levofloxacin—Back pain—Lisinopril—dilated cardiomyopathy	0.000577	0.00159	CcSEcCtD
Levofloxacin—Somnolence—Furosemide—dilated cardiomyopathy	0.000577	0.00158	CcSEcCtD
Levofloxacin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000573	0.00158	CcSEcCtD
Levofloxacin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000564	0.00155	CcSEcCtD
Levofloxacin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000562	0.00154	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00056	0.00154	CcSEcCtD
Levofloxacin—Fatigue—Furosemide—dilated cardiomyopathy	0.000559	0.00154	CcSEcCtD
Levofloxacin—Tremor—Lisinopril—dilated cardiomyopathy	0.000559	0.00154	CcSEcCtD
Levofloxacin—Pain—Furosemide—dilated cardiomyopathy	0.000555	0.00152	CcSEcCtD
Levofloxacin—Constipation—Furosemide—dilated cardiomyopathy	0.000555	0.00152	CcSEcCtD
Levofloxacin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000553	0.00152	CcSEcCtD
Levofloxacin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000551	0.00151	CcSEcCtD
Levofloxacin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000545	0.0015	CcSEcCtD
Levofloxacin—Malaise—Lisinopril—dilated cardiomyopathy	0.000538	0.00148	CcSEcCtD
Levofloxacin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000536	0.00147	CcSEcCtD
Levofloxacin—Syncope—Lisinopril—dilated cardiomyopathy	0.000535	0.00147	CcSEcCtD
Levofloxacin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000534	0.00147	CcSEcCtD
Levofloxacin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000534	0.00147	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00053	0.00146	CcSEcCtD
Levofloxacin—TOP2A—Gastric Cancer Network 2—EGFR—dilated cardiomyopathy	0.000528	0.00794	CbGpPWpGaD
Levofloxacin—Palpitations—Lisinopril—dilated cardiomyopathy	0.000527	0.00145	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000527	0.00791	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000524	0.00144	CcSEcCtD
Levofloxacin—Cough—Lisinopril—dilated cardiomyopathy	0.00052	0.00143	CcSEcCtD
Levofloxacin—Urticaria—Furosemide—dilated cardiomyopathy	0.000515	0.00142	CcSEcCtD
Levofloxacin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000513	0.00141	CcSEcCtD
Levofloxacin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000513	0.00141	CcSEcCtD
Levofloxacin—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000512	0.00769	CbGpPWpGaD
Levofloxacin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000508	0.0014	CcSEcCtD
Levofloxacin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000508	0.0014	CcSEcCtD
Levofloxacin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000508	0.0014	CcSEcCtD
Levofloxacin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000506	0.00139	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000504	0.00139	CcSEcCtD
Levofloxacin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000502	0.00138	CcSEcCtD
Levofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000501	0.00753	CbGpPWpGaD
Levofloxacin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000496	0.00136	CcSEcCtD
Levofloxacin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000491	0.00135	CcSEcCtD
Levofloxacin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000487	0.00134	CcSEcCtD
Levofloxacin—Oedema—Lisinopril—dilated cardiomyopathy	0.000487	0.00134	CcSEcCtD
Levofloxacin—Infection—Lisinopril—dilated cardiomyopathy	0.000483	0.00133	CcSEcCtD
Levofloxacin—Shock—Lisinopril—dilated cardiomyopathy	0.000479	0.00132	CcSEcCtD
Levofloxacin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000478	0.00131	CcSEcCtD
Levofloxacin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000476	0.00131	CcSEcCtD
Levofloxacin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000475	0.00131	CcSEcCtD
Levofloxacin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000473	0.0013	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—TUBB—dilated cardiomyopathy	0.000471	0.00708	CbGpPWpGaD
Levofloxacin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00047	0.00129	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000469	0.00705	CbGpPWpGaD
Levofloxacin—Asthenia—Furosemide—dilated cardiomyopathy	0.000465	0.00128	CcSEcCtD
Levofloxacin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000464	0.00127	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000461	0.00693	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000459	0.0069	CbGpPWpGaD
Levofloxacin—Pruritus—Furosemide—dilated cardiomyopathy	0.000459	0.00126	CcSEcCtD
Levofloxacin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000455	0.00125	CcSEcCtD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000449	0.00674	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000449	0.00674	CbGpPWpGaD
Levofloxacin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000444	0.00122	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000443	0.00122	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000441	0.00663	CbGpPWpGaD
Levofloxacin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00044	0.00121	CcSEcCtD
Levofloxacin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000437	0.0012	CcSEcCtD
Levofloxacin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000434	0.00119	CcSEcCtD
Levofloxacin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000433	0.00119	CcSEcCtD
Levofloxacin—Dizziness—Furosemide—dilated cardiomyopathy	0.000429	0.00118	CcSEcCtD
Levofloxacin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000428	0.00118	CcSEcCtD
Levofloxacin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000423	0.00116	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00042	0.00115	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—EMD—dilated cardiomyopathy	0.00042	0.00631	CbGpPWpGaD
Levofloxacin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00042	0.00115	CcSEcCtD
Levofloxacin—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000418	0.00628	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000417	0.00627	CbGpPWpGaD
Levofloxacin—Pain—Lisinopril—dilated cardiomyopathy	0.000416	0.00114	CcSEcCtD
Levofloxacin—Constipation—Lisinopril—dilated cardiomyopathy	0.000416	0.00114	CcSEcCtD
Levofloxacin—Vomiting—Furosemide—dilated cardiomyopathy	0.000412	0.00113	CcSEcCtD
Levofloxacin—Rash—Furosemide—dilated cardiomyopathy	0.000409	0.00112	CcSEcCtD
Levofloxacin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000409	0.00112	CcSEcCtD
Levofloxacin—Headache—Furosemide—dilated cardiomyopathy	0.000406	0.00112	CcSEcCtD
Levofloxacin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000401	0.0011	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000398	0.00109	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000395	0.00593	CbGpPWpGaD
Levofloxacin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000387	0.00106	CcSEcCtD
Levofloxacin—Nausea—Furosemide—dilated cardiomyopathy	0.000385	0.00106	CcSEcCtD
Levofloxacin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000385	0.00106	CcSEcCtD
Levofloxacin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000385	0.00106	CcSEcCtD
Levofloxacin—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000367	0.00551	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000359	0.000985	CcSEcCtD
Levofloxacin—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000352	0.00529	CbGpPWpGaD
Levofloxacin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000349	0.00096	CcSEcCtD
Levofloxacin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000344	0.000946	CcSEcCtD
Levofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.000337	0.00507	CbGpPWpGaD
Levofloxacin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000333	0.000915	CcSEcCtD
Levofloxacin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000322	0.000884	CcSEcCtD
Levofloxacin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000309	0.00085	CcSEcCtD
Levofloxacin—Rash—Lisinopril—dilated cardiomyopathy	0.000307	0.000843	CcSEcCtD
Levofloxacin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000307	0.000842	CcSEcCtD
Levofloxacin—Headache—Lisinopril—dilated cardiomyopathy	0.000305	0.000838	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000292	0.00439	CbGpPWpGaD
Levofloxacin—Nausea—Lisinopril—dilated cardiomyopathy	0.000289	0.000794	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000287	0.00431	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000279	0.0042	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000277	0.00416	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000271	0.00408	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000266	0.00399	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000262	0.00393	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000255	0.00383	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000255	0.00383	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	0.00025	0.00375	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000246	0.00369	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000237	0.00356	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000236	0.00355	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000229	0.00344	CbGpPWpGaD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000227	0.00341	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000218	0.00328	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000212	0.00319	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000212	0.00319	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000206	0.00309	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	0.000205	0.00308	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000197	0.00297	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000191	0.00288	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000185	0.00277	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00018	0.0027	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000148	0.00222	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000143	0.00216	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00014	0.00211	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	0.000135	0.00203	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000132	0.00198	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000123	0.00185	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	0.000122	0.00183	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000119	0.00179	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000117	0.00177	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000116	0.00174	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000116	0.00174	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000108	0.00162	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000104	0.00157	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000101	0.00152	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000101	0.00152	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	9.64e-05	0.00145	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	9.64e-05	0.00145	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	9.45e-05	0.00142	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.11e-05	0.00137	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.1e-05	0.00137	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	8.93e-05	0.00134	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	8e-05	0.0012	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	7.84e-05	0.00118	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	7.83e-05	0.00118	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	7.37e-05	0.00111	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	6.66e-05	0.001	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	6.25e-05	0.00094	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.92e-05	0.00089	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	5.88e-05	0.000884	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	5.32e-05	0.000799	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.16e-05	0.000776	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.83e-05	0.000725	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.54e-05	0.000682	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.3e-05	0.000647	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.1e-05	0.000617	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.06e-05	0.00061	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.87e-05	0.000581	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	3.31e-05	0.000498	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.24e-05	0.000487	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	3.23e-05	0.000485	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.16e-05	0.000475	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	2.9e-05	0.000437	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.84e-05	0.000427	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.35e-05	0.000353	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.81e-05	0.000272	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.76e-05	0.000265	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.59e-05	0.000238	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.44e-05	0.000217	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.41e-05	0.000211	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.27e-05	0.00019	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.11e-05	0.000168	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	0.000163	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	9.78e-06	0.000147	CbGpPWpGaD
